Perrigo Other Non-Current Liabilities 2010-2024 | PRGO

Perrigo other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Perrigo Annual Other Non-Current Liabilities
(Millions of US $)
2023 $560
2022 $623
2021 $530
2020 $648
2019 $515
2018 $443
2017 $430
2016 $462
2015 $346
2015 $383
2014 $293
2013 $213
2012 $165
2011 $167
2010 $108
2009 $86
Perrigo Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $660
2024-06-30 $535
2024-03-31 $526
2023-12-31 $560
2023-09-30 $614
2023-06-30 $659
2023-03-31 $638
2022-12-31 $623
2022-09-30 $573
2022-06-30 $577
2022-03-31 $554
2021-12-31 $530
2021-09-30 $566
2021-06-30 $554
2021-03-31 $533
2020-12-31 $648
2020-09-30 $562
2020-06-30 $530
2020-03-31 $510
2019-12-31 $515
2019-09-30 $551
2019-06-30 $547
2019-03-31 $555
2018-12-31 $443
2018-09-30 $424
2018-06-30 $415
2018-03-31 $429
2017-12-31 $430
2017-09-30 $435
2017-06-30 $445
2017-03-31 $459
2016-12-31 $462
2016-09-30 $457
2016-06-30 $423
2016-03-31 $409
2015-12-31 $346
2015-09-30 $375
2015-06-30 $372
2015-03-31 $301
2014-12-31 $291
2014-09-30 $287
2014-06-30 $293
2014-03-31 $275
2013-12-31 $245
2013-09-30 $235
2013-06-30 $213
2013-03-31 $185
2012-12-31 $174
2012-09-30 $166
2012-06-30 $165
2012-03-31 $163
2011-12-31 $183
2011-09-30 $182
2011-06-30 $167
2011-03-31 $158
2010-12-31 $147
2010-09-30 $139
2010-06-30 $108
2010-03-31 $105
2009-12-31 $106
2009-09-30 $99
2009-06-30 $86
2009-03-31 $74
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.513B $4.656B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.127B 25.27
Stryker (SYK) United States $138.991B 31.32
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Insulet (PODD) United States $18.698B 74.46
Baxter (BAX) United States $15.062B 9.80
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Bio-Rad Laboratories (BIO) United States $9.168B 31.16
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00